SLC2A5 and cancer: When combined with D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) to form PCL-PEG-Fru/TPGS mixed micelles (PPF MM), these nanocarriers demonstrated a promising potential for GLUT5-mediated, cell-specific delivery in cancer therapy (Fig. 3).